Telerehabilitation program for improving sexual function and reducing pain in menopausal women
Official title: Effectiveness of a Telerehabilitation Program for Improving Sexual Function and Reducing Pain in Menopausal Women With Dyspareunia: Protocol of a Randomized Clinical Trial.
Run by Instituto Médico Tecnológico SL · NCT06710002 · Data updated 2026-11-12
This study is testing a telerehabilitation program to see if it can help menopausal women with painful sex feel better and improve their overall quality of life compared to regular in-person therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years to 65 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Instituto Médico Tecnológico SL Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Barcelona, Spain) |
| Status | Recruiting |
| Started | May 5, 2025 |
| Main results expected | March 2026 |
| Study ends | March 2026 |
| Registry record updated | May 23, 2025 |
| Trial ID | NCT06710002 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are menopausal women aged 45 to 65 who have been experiencing dyspareunia for at least three months.
✕Probably not a fit
Patients with certain medical conditions, such as active cancer or neuromuscular diseases, or those who have undergone recent pelvic surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of a telerehabilitation program compared to traditional face-to-face physiotherapy for menopausal women experiencing dyspareunia. It will assess improvements in sexual function, pain reduction, and quality of life using validated instruments such as the Female Sexual Function Index and the Visual Analogue Scale. The study will also explore the potential benefits of combining telerehabilitation with in-person treatment and monitor adherence and satisfaction levels among participants.
Why it matters
Potential benefit: If successful, this program could provide a convenient and effective treatment option for menopausal women suffering from sexual dysfunction and pain.
How similar studies have gone: While telerehabilitation has shown promise in various health fields, this specific approach comparing it to face-to-face physiotherapy in this context is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female * Age from 45 to 65 years. * Menopausal * Suffer dyspareunia for 3 months of evolution. * Willing to complete study questionnaires and informed consent study. Exclusion Criteria: * Pacemaker or other types of electronic implant. * Thrombophlebitis. * Skin hypersensitivity or rejection of manual contact. * Active or previous treatment with chemotherapy or radiotherapy in the pelvic area. * Wounds or burns in the pelvic area. * Allergy to nickel and chromium. * Other pelvic floor physiotherapy treatments during the study intervention. * Other medical and surgical treatments in the pelvic region, such as muscle infiltrations or nerve blocks during the study intervention. * Surgical intervention in the pelvic area in the last 3 months. * Fibromyalgia. * Oncological processes that affect the sacrum. * Systemic diseases (infectious, vascular, endocrine, metabolic or neoplastic conditions). * Neuromuscular diseases (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Myasthenia Gravis or spinal muscular atrophy). * Myelopathy and Osteomyelitis. * Diseases that cause alterations of the central nervous system (traumatic or vascular spinal cord injury). * Neurological or metabolic conditions that affect the ability to respond (Diabetes, Parkinson's disease, senile dementia, etc). * Serious mental disorder.
Where it's running
-
RAPbarcelona
Barcelona, Spain, Spain Recruiting
Study contacts
- Study coordinator: Paula Sanfeliu Rosell, MSc
- Email: fisiopaulasanfeliu@gmail.com
- Phone: +34 648222751
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nonhormonal vulvovaginal gel to relieve menopausal vulvovaginal symptoms
This will test a hormone-free vulvovaginal gel in postmenopausal women with genitourinary syndrome of menopause to see if it reduces vaginal atrophy symptoms and improves daily quality of life.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Resveratrol and Estrogen Receptors in Postmenopausal Women with CAD
This study tests whether taking resveratrol is safe and can change estrogen-related markers in postmenopausal women with coronary artery disease.
-
Ashoka Bark and Shatavari for Menopause
This 12-week study tests whether a daily Ashoka Bark and Shatavari supplement helps reduce menopausal symptoms in postmenopausal women compared with a placebo.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
Pain and period life: does menstrual cycle or menopause change pain during root canals?
This study will see if pain during a root canal varies with menstrual cycle phase or menopausal status in adult patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.